FTSE falters on beer and drugs

clock

Stocks on the FTSE 100 index are heading south again this morning, led by brewer SABMiller and pharmaceutical firm Shire.

The FTSE 100 index was down 26.7 points or 0.5% to 5870 in early trading, prompted by SAB Miller, the world's third-largest beer maker, which fell 2.7% to 997p and Shire which has also fallen 1.7% to 817p. ITV, the commercial broadcaster, has also dropped 0.3% to 98.75p as the FT reported the company's flagship channel ITV1 will have a 20% in advertising revenue in the final quarter of the year. Asian stocks closed the day down generally, led by exporters such as Toyota Motor and Samsung Electronics as US reports suggested growth in the world's largest economy is weakening. Share values...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Partner Insight: Debt, deficits, and market resilience: Is your portfolio prepared?

Partner Insight: Debt, deficits, and market resilience: Is your portfolio prepared?

The world is awash in debt. In the US, government borrowing has surged past 100% of GDP, and the fiscal deficit is at a level typically seen in wartime. Other major economies are in similar situations. So, what does this deluge of debt mean for markets?

Orbis Investments
clock 15 May 2025 • 5 min read
Three Invesco funds fail to deliver value to investors

Three Invesco funds fail to deliver value to investors

Manager's annual assessment found some poor performance

clock 14 May 2025 • 2 min read
Darius McDermott: Old demographics, new innovations — so why isn't healthcare booming?

Darius McDermott: Old demographics, new innovations — so why isn't healthcare booming?

'The sector should be flying — but it isn't'

Darius McDermott
clock 08 May 2025 • 5 min read